Generic Name	Synonyms	World Status	Primary Therapy Description	Any Indication	Notes
AIDS vaccine, DNA, PowderMed	AIDS vaccine, DNA, Glaxo HIV vaccine, DNA, PowderMed	Phase I Clinical Trial	Recombinant vaccine	Infection, HIV/AIDS	Collaboration with GSK. In Phase I trials in healthy HIV-negative volunteers
antiallergic, Celldex	antiallergic, PowderMed	Preclinical	Gene therapy	Allergy, general Asthma	In collaboration with Medarex subsidiary
HBV DNA vaccine, PowderMed	pdpSC18 pWRG7128	Phase I Clinical Trial	Recombinant vaccine	Infection, hepatitis-B virus	Phase I results expected in 2007
HPV vaccine, DNA, PowderMed		Preclinical	Recombinant vaccine	Infection, human papilloma virus	Clinical trials expected in 2007
HSV-2 DNA vaccine, PowderMed	pPJV7630	Phase I Clinical Trial	Recombinant vaccine	Infection, herpes simplex virus	Novartis has option for US rights
influenza vaccine, avian, Powd	H5N1 vaccine, PowderMed	Phase I Clinical Trial	Recombinant vaccine	Infection, influenza virus prophylaxis	Trial completion anticipated in 2007
influenza vaccine, DNA, Powder		Phase I Clinical Trial	Recombinant vaccine	Infection, influenza virus prophylaxis	Trivalent trial results expected in May 2007
NY-ESO-1 vaccine, PowderMed	lung cancer vaccine, Ludwig lung cancer vaccine, PowderMed NY-ESO-1 vaccine, Ludwig	Phase I Clinical Trial	Gene therapy	Cancer, lung, non-small cell	In US clinical trials